환영사

관계자 여러분

2017년 7월 10일부터 13일까지 보스턴에서 개최되는 Drug Discovery and Therapy World Congress 2017의 참가를 환영합니다.

이 컨퍼런스는 세계 각국의 산학계에서 많은 연구자가 참가하여 Drug Discovery와 치료 최신 동향에 대해 논의하는 대규모 이벤트로, 40개의 테마별 세션에서 약 400건의 연구 발표가 진행되고 포스터 발표도 예정되어 있습니다.

2017년 컨퍼런스에서는 Drug Discovery와 치료에 관련된 다양한 토픽이 다루어질 예정입니다. 주요 토픽은 의약품 연구개발, 중개의학, 재생의료, 실현 기술, 구조생물학, 약물전달과 표적화, 항감염약, 생물제제, 중추신경계 질환 치료제의 Drug Discovery와 치료, 당뇨병 및 비만 치료제의 Drug Discovery와 치료, 부인과 질환 치료제의 Drug Discovery와 치료, 전임상 연구의 Drug Discovery, 심혈관질환 치료제의 Drug Discovery와 치료, 종양학, 프로세스 화학과 의약품 제조, 폐질환 치료제의 Drug Discovery와 치료, 환자 치료와 케어 분야의 최근 진보, 염증과 면역학, 혁신적인 Drug Discovery 방법과 나노테크놀러지, 의약품 바이오테크놀러지, 프로테오믹스와 바이오인포매틱스, 약물유전체학, 단백질 및 펩티드 과학, 약물 대사, 의화학 분야의 핫토픽, 의료용 영상 처리 기술, HIV 연구 분야의 핫토픽, 컴퓨터를 이용한 약제 설계와 스크리닝, 조합화학(Combinatorial Chemistry), High-throughput Screening과 실험실 자동화, 약제 표적 분야의 핫토픽, 천연물 분야의 핫토픽, 생물활성화합물의 입체 선택적 합성, 분광법 분야의 최근 진보, Drug Discovery의 대학 CRO와 제약 업계 제휴 등입니다.

이 컨퍼런스의 목적은 Drug Discovery와 약물 치료에 관한 연구와 기술의 급속한 변화가 연구자 및 의사에게 초래하는 새로운 기회와 문제에 관한 많은 흥미로운 견해를 제시하는 것입니다.

이 컨퍼런스는 매력적이며 지적인 환경인 보스턴에 각 분야를 선도하는 세계적인 연구자가 모이는 주목도 높은 이벤트입니다.

보스턴에서 만납시다!

On behalf of the Organizing Committee
DDTWC 2017


ABOUT THE PRESIDENTS



PROF. ATTA-UR-RAHMAN, FRS
UNESCO Science Laureate

Drug Discovery and Therapy World Congress 2017

Prof. Atta-ur-Rahman obtained his Ph.D. in organic chemistry from Cambridge University (1968). He has 1056 publications in several fields of organic chemistry including 740 research publications, 37 international patents, 69 chapters in books and, 210 books published largely by major U.S. and European presses. He is the Editor-in-Chief of four European Chemistry journals. He is Editor of the world's leading encyclopedic series of volumes on natural products "Studies in Natural Product Chemistry" 50 volumes of which have been published under his Editorship during the last two decades. Eighty two students have completed their Ph.D. degrees under his supervision.

Prof. Rahman is the first scientist from the Muslim world to have won the prestigious UNESCO Science Prize (1999) in the 35 year old history of the Prize. He was elected as Fellow of Royal Society (London) in July 2006. He has been conferred honorary doctorate degrees by many universities including the degree of Doctor of Science (Sc.D.) by the Cambridge University (UK) (1987), Honorary degree of Doctor of Education by Coventry University UK (2007), Honorary D.Sc. degree by Bradford University (2010), Honorary Ph.D. by Asian Institute of Technology (2010) and Honorary Doctorate from King of Malaysia (University of Technology, Mara, 2011). He was elected Honorary Life Fellow of Kings College, Cambridge University, UK in 2007. Prof. Atta-ur-Rahman was conferred the TWAS (Italy) Prize for Institution Building in October 2009 in recognition of his contributions for bringing about revolutionary changes in the higher education sector in Pakistan. The Austrian government has honoured him with its highest civil award ("Grosse Goldene Ehrenzeischen am Bande") (2007) in recognition of his eminent contributions. He is President of Network of Academies of Sciences of Islamic Countries (NASIC), Foreign Fellow of Korean Academy of Sciences, and Foreign Fellow of the Chinese Chemical Society. Prof. Atta-ur-Rahman has won the International Scientific Corporation Award by Chinese Academy of Science (CAS) for building scientific collaborations between China and Pakistan (2014), has been awarded prestigious "Einstein Professorship" by Chinese Academy of Sciences (CAS), 2013 and has been awarded highest award "Friendship Award of China" on September 28, 2014.He has recently been appointed as Consultant, Education Forum Asia (2015-2020) and Foreign Member of Chinese Academy of Sciences (2015).

Prof. Atta-ur-Rahman is the President of Network of Academies of Science in Countries of the Organization of Islamic Conference (NASIC). Prof. Atta-ur-Rahman has been elected as the President of the Pakistan Academy of Sciences twice from 2003-2006 and 2011 - 2014. He was the Federal Minister for Science and Technology (14th March, 2000 - 20th November, 2002), Federal Minister of Education (2002) and Chairman of the Higher Education Commission with the status of a Federal Minister from 2002-2008. Prof. Atta-ur-Rahman was the Coordinator General of COMSTECH, an OIC Ministerial Committee comprising the 57 Ministers of Science & Technology from 57 OIC member countries from 1996 to 2012. He is Distinguished National Professor as well as Professor Emeritus at Karachi University.

In recognition of his global outstanding services to the development of Science and Technology the largest university in Malaysia, University of Technology Mara, Malaysia UiTM, has established an institution entitled, "Atta-ur-Rahman Institute of Natural Product Discovery (RiND)" in 2013., The National University of Science and Technology (NUST) has also established an Institute "Atta-ur-Rahman School of Applied Biosciences (ASAB)" at their university in Islamabad in 2011.

Prof. Dr. Atta-ur-Rahman is the most decorated scientist of Pakistan having won four civil awards by the government of Pakistan, including Tamgha-i-Imtiaz (1983), Sitara-i-Imtiaz (1991), Hilal-i-Imtiaz (1998), and the highest national civil award Nishan-i-Imtiaz (2002).



Ferid Murad
Nobel Laureate M.D.

Drug Discovery and Therapy World Congress 2017

Ferid Murad, Nobel Laureate M.D. is Director Emeritus at the Brown Foundation Institute of Molecular Medicine for the prevention of Human Diseases, Director of the IMM Center for Cell Signaling, Regental Professor and John S. Dunn Sr. Distinguished Chair in Physiology and Medicine, Texas Nobel Scholar at the University of Texas at Houston, and Director of the UT Health Science Center at Houston Program in Intracellular Signaling.

Dr. Murad completed his undergraduate work at DePauw University and received his M.D. and Ph.D. from Case Western Reserve University. He had a medical residency at Massachusetts General Hospital and a fellowship at NIH in the Heart Institute. He was on the faculty at the University of Virginia 1970-81 as Director of the Clinical Research Center and Director of the Division of Clinical Pharmacology with appointments in Medicine and Pharmacology. He was Chief of Medicine at Palo Alto Veterans Hospital 1981-88, Associate Chairman of Medicine 1982-86 and Chairman of Medicine 1986-88 at Stanford University. He was Vice President of Research and Development at Abbott Laboratories 1988-93 and Professor at Northwestern University.

Dr. Murad has been active in both academic medicine and industry throughout his distinguished career. He has founded and co-founded five biotechnology companies and has advised many cities and government leaders about technology development. His work has concentrated on the field of cell signaling and signal transduction systems.

In 1998, Dr. Murad received the Nobel Prize in Medicine for his work with nitric oxide - a colorless, odorless gas that signals blood vessels to relax and widen, which in turn lowers blood pressure. He continues research which leads to a better understanding of how information is transmitted between cells.

Among his many other awards and honors, Dr. Murad received the prestigious Albert and Mary Lasker Basic Medical Research Award in 1996, the American Heart Association Ciba Award in 1988, and the Baxter Award for Distinguished Research in the Biomedical Sciences from the Association of American Medical Colleges in 2000. He also received the American Society of Clinical Pharmacology Distinguished Research Prize in 2005 and the President"s Scholar Award from the University of Texas-Houston Health Science Center in 2006.

He is a member of the National Academy of Sciences, Institute of Medicine of the National Academy of Sciences, Fellow of the American Academy of Arts and Sciences, Texas Academy of Medicine, and Engineering and Science Technology. He is also a member of several foreign academies and is an Honorary or Adjunct Professor at a number of universities. Dr. Murad also serves on the Board of Directors and Scientific Advisory Boards of a number of public and private companies and various foundations and universities. About 140 trainees have worked in his laboratories who are currently academic or pharmaceutical industry leaders around the world.